Global pharmaceutical company Galderma has started a new campaign that will offer clinics a mix of expert training, guidance, offers, and clinic campaign assets.
Aesthetics reports on the highlights from the British Association of Cosmetic Nurses Autumn Conference
Pharmaceutical company Galderma invited guests to a celebratory breakfast in the Duncan Room at the Charlotte Street Hotel for the 20th anniversary of Restylane.
Laser manufacturer Cynosure celebrates 30 years this July with a month-long celebration.
A new marketing study has indicated a high level of patient satisfaction following lip enhancements.
Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.
Two of the industry’s leading companies could become one if a multi-million dollar bid by Galderma to acquire Q-Med goes ahead. In a joint venture between L’Oreal and Nestle. Galderma, the makers of Azzalure®, launched a reported $970 million bid for the Swedish manufacturer of Restylane® at the end of 2010.
Aesthetic practitioner Dr Ravi Jain, the owner of Riverbanks Wellness, held an anniversary event to celebrate the clinic’s 10th year in business on September 21.
Global pharmaceutical company Galderma is relaunching the poly-L-lactic acid (PLLA) filler Sculptra.
The Food and Drug Administration (FDA) has approved Restylane Refyne and Restylane Defyne dermal fillers from Galderma for the treatment of nasolabial folds.